Simultaneous densitometric TLC analysis of atorvastatin calcium and fenofibrate in the bulk drug and in pharmaceutical formulations

Journal of Planar Chromatography - Modern TLC

Volumn 22, Issue 5, 2009, Pages 355-358

  Shirkhedkar, Atul A ^a   Surana, Sanjay J ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Atorvastatin calcium; Fenofibrate; TLC densitometry; Validation

Indexed keywords

ACCURATE ANALYSIS; ATORVASTATIN; ATORVASTATIN CALCIUM; BULK DRUGS; CALIBRATION PLOT; DENSITOMETRY; DOSAGE FORMS; FENOFIBRATE; LIMITS OF DETECTION; LINEAR RELATIONSHIPS; MOBILE PHASE; PHARMACEUTICAL DOSAGE FORMS; PHARMACEUTICAL FORMULATION; POLYNOMIAL REGRESSION; QUANTITATIVE ANALYSIS; SIMULTANEOUS ANALYSIS; STATISTICAL ANALYSIS; TLC ANALYSIS; TRIETHYLAMINES; VASCULAR DISEASE;

ALUMINUM FOIL; CALCIUM; CALCIUM ALLOYS; CHEMICAL ANALYSIS; DRUG DOSAGE; METHANOL; SILICA; SILICA GEL; TOLUENE;

DRUG PRODUCTS;

ATORVASTATIN; FENOFIBRATE; METHANOL; SILICA GEL; TOLUENE; TRIETHYLAMINE;

ALUMINUM FOIL; ARTICLE; CHEMICAL STRUCTURE; DENSITOMETRY; TABLET FORMULATION; THIN LAYER CHROMATOGRAPHY;

EID: 71049177826     PISSN: 09334173     EISSN: None     Source Type: Journal    
DOI: 10.1556/JPC.22.2009.5.7     Document Type: Article

References (19)

1. R.H. Superko, S. Madan, D. Tonnemacher, N. Chronos, B. Garrett, D. Sheehan, E. Raul, S. Frohwein, K. McGrath, J. Am. College Cardiol. 41 (2003) 316-320.
2. Clarke's Analysis of Drug and Poisons in Pharmaceuticals, Body Fluids and Postmortem Material, 3rd edn, The Pharmaceutical Press, Great Britain., pp. 654.
3. British Pharmacopoeia, H. M. Stationary Office, London, 2005. pp. 545.
4. E. Sidika, S.A. Esra, E. Lale, F. Samiye, J. Pharm. Biomed. Anal. 33 (2003) 1017-1023.
5. E.E. Mann, C.W. Palmer, S.R. Hagen, J. Liq. Chromatogr. Relat. Technol. 20 (1997) 2441-2450.
6. B. Gholamreza, M. Bahareh, M. Shahla, K. Amir, J. Chromatogr. B 826 (2005) 41-45.
7. N. Erk, Anal. Lett. 36 (2003) 2699-2711.
8. W.W. Bullen, R.A. Miller, R.N. Hayes, J. Am. Soc. Mass Spectrom. 10 (1999) 55-66.
9. M. Jemal, Z. Ouyang, B.C. Chen, D. Teitz, Rapid Commun. Mass. Spectrom. 13 (1999) 1003-1015.
10. Y.Y. Shum, N. Huang, G. Walter, A. Black, C. Serkerke, T. Chang, L.R. Whitefield, Ther. Drug Monit. 20 (1998) 41-49.
11. E. Nevin, Crit. Rev. Anal. Chem. 34 (2004) 1-7.
12. A. El-Gindy, S. Emara, M.K. Mesbah, G.M. Hadad, II Farmaco 60 (2005) 425-438.
13. X. Ji, C. Ye, Zhongguo Yaoke Daxue Xucbao 18 (1987) 284-286.
14. L.M. Pauline, D.A. Brian, S.W. Roger, B.D. Bruce, C.D. Teny, E. Jean-Claude, J. Pharm. Biomed. Anal. 18 (1998) 383-395.
15. C. Yardimci, N. Ozaltin, Anal. Bioanal. Chem. 378 (2004) 495-498.
16. Nagaraj, V. Kalamkar, R. Mashru, Anal. Sci. 23 (2007) 445-451.
17. United States Pharmacopeia, 28th edn, Rockville, MD, The United States Pharmacopoeial Convention, Inc, 2005, pp. 2748-2750.
18. International Conference on Harmonisation, ICH/CPMP guidelines Q2 (R1), Validation of analytical procedures: Text and methodology, ICH, Geneva, Switzerland, 2005.
19. Reviewer Guidance, Validation of chromatographic methods, Food and Drug Administration, Centre for Drug Evaluation and Research, US Government Printing Office, Washington DC, 1994.